Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.

Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.

Item
http://www.wikidata.org/entity/Q34631533
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapyOutpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.Treatment of locally advanced head and neck cancer: historical and critical review.Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence populationA phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma.Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge.Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study.Nutlin-3, A P53-Mdm2 Antagonist For Nasopharyngeal Carcinoma Treatment.Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.CT-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma.Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.Association between the p73 G4C14-to-A4T14 polymorphism and risk of nasopharyngeal carcinoma: a case-control and family-based study.Prognostic significance of expression of VEGF and Cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR.
P2860

Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.

Item
http://www.wikidata.org/entity/Q34631533
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@ast
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@en
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@nl
type
label
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@ast
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@en
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@nl
prefLabel
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@ast
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@en
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698